I had another look at the results and like very much what I see. I acknowledge and agree with what Pickem said earlier on another thread. I think it likely that the last cohort ( highest dose ) lifted the overall results compared with interim results ( lower dose cohorts) released last year. It has lifted the overall median survival by 2.6 months. If this is the case, the highest dose results, on their own, look very, very good with a median overall survival of around 22 months. Also, we know the doses in this trial are likely sub therapeutic. Double that maximum final dose of 1200mg is being trialled in other trials. This breakdown of the efficacy of different doses will be revealed at the conference.
- Forums
- ASX - By Stock
- NOX
- Lupin results: Final cohort ( highest dose)
Lupin results: Final cohort ( highest dose)
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
6.9¢ |
Change
-0.003(4.17%) |
Mkt cap ! $20.16M |
Open | High | Low | Value | Volume |
6.9¢ | 6.9¢ | 6.9¢ | $3.085K | 44.70K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 22852 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 1310 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 22852 | 0.069 |
1 | 10000 | 0.068 |
2 | 47278 | 0.066 |
1 | 15000 | 0.065 |
2 | 89000 | 0.063 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 1310 | 1 |
0.072 | 1237 | 1 |
0.074 | 50000 | 1 |
0.076 | 4999 | 1 |
0.079 | 12000 | 1 |
Last trade - 15.09pm 02/08/2024 (20 minute delay) ? |
Featured News
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
NOX (ASX) Chart |